Insights

US Market Leader Aurobindo is the largest generic pharma company in the United States, presenting a strong positioning to leverage for new US-focused product launches, partnerships, and premium library expansions.

Regulatory Footprint With 30+ facilities approved by USFDA, UK MHRA, EDQM, PMDA, WHO and others, there is a robust regulatory backbone suitable for fast-track approvals, co-development, and high-volume supply contracts.

Diversified Portfolio Aurobindo operates across eight therapeutic areas including CNS, ARV, CVS, antibiotics, oncology and diabetes, indicating cross-sell opportunities to existing customers and cadence-driven lifecycle management.

Recent Product Launch The launch of generic Advair Diskus (fluticasone-salmeterol) in the US signals capability in respiratory generics and potential for expanded inhalation portfolio and license/infringement mitigation partnerships.

Strategic Partnerships Recent asset divestiture and regulatory milestones create openings for distribution collaborations, manufacturing capacity leverage, and API supply agreements with US and international buyers and distributors.

Similar companies to AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD Tech Stack

AUROBINDO PHARMA LTD uses 8 technology products and services including Power BI, jsDelivr, Joomla, and more. Explore AUROBINDO PHARMA LTD's tech stack below.

  • Business Intelligence
  • jsDelivr
    Content Delivery Network
  • Content Management System
  • Content Management System
  • Cookie Notice
    Cookie Compliance
  • Office Suites
  • Ubuntu
    Operating Systems
  • Windows Server
    Operating Systems

Media & News

AUROBINDO PHARMA LTD's Email Address Formats

AUROBINDO PHARMA LTD uses at least 4 email formats:
AUROBINDO PHARMA LTD Email FormatsExamplePercentage
First.Last@aurobindo.comJohn.Doe@aurobindo.com
92%
FLast@aurobindo.comJDoe@aurobindo.com
5%
First_Last@aurobindo.comJohn_Doe@aurobindo.com
2%
First@aurobindo.comJohn@aurobindo.com
1%

Frequently Asked Questions

What is AUROBINDO PHARMA LTD's official website and social media links?

Minus sign iconPlus sign icon
AUROBINDO PHARMA LTD's official website is aurobindo.com and has social profiles on LinkedIn.

How much revenue does AUROBINDO PHARMA LTD generate?

Minus sign iconPlus sign icon
As of August 2026, AUROBINDO PHARMA LTD's annual revenue is estimated to be $1B - $10B.

What is AUROBINDO PHARMA LTD's SIC code and NAICS code?

Minus sign iconPlus sign icon
AUROBINDO PHARMA LTD's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does AUROBINDO PHARMA LTD have currently?

Minus sign iconPlus sign icon
As of August 2026, AUROBINDO PHARMA LTD has approximately 15K employees across 6 continents, including Asia, North America and Europe. Key team members include Ceo-Europe: V. M. M., Chief Executive Officer: R. A. and Chief Executive Officer: A. R. Explore AUROBINDO PHARMA LTD's employee directory with LeadIQ.

What industry does AUROBINDO PHARMA LTD belong to?

Minus sign iconPlus sign icon
AUROBINDO PHARMA LTD operates in the Pharmaceutical Manufacturing industry.

What technology does AUROBINDO PHARMA LTD use?

Minus sign iconPlus sign icon
AUROBINDO PHARMA LTD's tech stack includes Power BI, jsDelivr, Joomla, WordPress, Cookie Notice, Office 365, Ubuntu and Windows Server.

What is AUROBINDO PHARMA LTD's email format?

Minus sign iconPlus sign icon
AUROBINDO PHARMA LTD's email format typically follows the pattern of First.Last@aurobindo.com. Find more AUROBINDO PHARMA LTD email formats with LeadIQ.

When was AUROBINDO PHARMA LTD founded?

Minus sign iconPlus sign icon
AUROBINDO PHARMA LTD was founded in 1986.
AUROBINDO PHARMA LTD logo

AUROBINDO PHARMA LTD

Pharmaceutical ManufacturingTelangana, India10001+ Employees

Aurobindo Pharma Limited is an integrated global pharmaceutical company headquartered in Hyderabad, Telangana, India. It develops, manufactures, and markets a broad range of generic medicines, branded specialty drugs, and active pharmaceutical ingredients for markets in more than 150 countries. The company is a major player in the generic space, with a substantial footprint in the United States where it is the largest generic pharmaceutical company, and a presence in Europe where it ranks in the top 10 in several countries. Its manufacturing and packaging network comprises multiple facilities approved by major regulators, including USFDA, UK MHRA, EDQM, PMDA, WHO, Health Canada, MCC, and ANVISA. The portfolio spans eight therapeutic areas—CNS, antiretrovirals, cardiovascular, antibiotics, gastroenterology, anti-diabetics, oncology, and dermatology—and is supported by a robust research and development framework. In June 2026, Aurobindo announced plans to develop a major biologics contract manufacturing facility in Telangana, with MSD Pharma named as anchor client, marking an expansion into biologics manufacturing.

Section iconCompany Overview

SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1986
Employees
10001+

Section iconFunding & Financials

  • $1B - $10B

    AUROBINDO PHARMA LTD's revenue is estimated to be in the range of $1B - $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.